- 12 oral surgery updates in 2026
- 5 ASC, MOB deals in California
- Hidden OR capacity challenges: 8 perioperative leaders on what’s draining surgical time
- The Aspen Group’s 3-year growth recap: 40 moves
- Florida State University set to acquire Tallahassee hospital
- How Confusing Financial Journeys Undermine Revenue and Trust
- How Confusing Financial Journeys Undermine Revenue and Trust
- Misalignment, Not Malice: Rethinking Generational Conflict in Healthcare
- If AI ‘adds friction, it fails’: How Mayo Clinic scales technology
- As maternity units close, AdventHealth restores OB care in rural Kansas
- Oklahoma officials warn of new opioid
- The new metrics of healthcare technology ROI: What matters to healthcare leaders
- Hoag to launch transplant center in 2027
- MercyOne hospital to transition labor and delivery services
- MercyOne hospital to transition labor and delivery services
- Southeast metros lead US population growth as national gains slow
- 8 Medicare Advantage numbers to know in 2026
- 17 Senate Dems push back on 2027 ACA proposal
- Providence hospital closes inpatient pediatric unit
- Michigan finalizes Medicaid mental health assessment policy changes
- 10 financial notes on USPI’s growth over the past 3 years
- 15 new orthopedic practice, center openings in Q1
- The oral surgery technological revolution
- From Anxiety to Action: How Ambulatory Leaders Are Rebuilding Margins in 2026
- Where GI training may fall short
- What it took to become the world’s first ASC to offer Stryker’s robotic knee tech
- Medtronic’s win in spinal cord stimulator lawsuit upheld
- How the Trump Administration Uses Migrant Kids To Find and Detain Family Members
- Heartland Dental’s 3-year growth recap: 30+ moves
- Cencora’s $10B+ physician acquisition spree: A breakdown
- Tennessee physician practice acquired
- The FTC is coming for healthcare consolidation: 10 things physicians need to know
- Adventist Health sees momentum from insourcing revenue cycle operations
- Oral GLP-1s, COVID preventatives: 3 more drugs in the pipeline, Optum says payers should watch
- Unlicensed dentistry cases, DSO deals, legislation & more: 10 dentistry updates in Virginia
- Missouri system debuts mobile behavioral health unit
- Yale researchers study GLP-1’s potential for SUD
- Texas dental school receives $6.5M to expand pediatric dental, medical programs
- North Carolina autism provider to expand therapy access
- $3M Verdict Links Social Media to Anxiety and Depression
- West Virginia hospital to end OB delivery services
- 6 DSOs making headlines
- California hospital’s finances improve, cash position remains ‘dire’
- 1 in 5 metro markets face inpatient monopoly: 7 notes
- Minnesota system faces uncertainty amid Medicare delays
- Ohio county approves behavioral health crisis center plan
- The White House Delays CDC Pick
- New COVID 'Cicada' Variant Is Spreading — What Experts Want You To Know
- Op-ed: Empathy meets efficiency—how the responsible use of AI can transform Medicare
- Family Caregivers Provide $1 Trillion In Annual Labor, AARP Says
- ‘Health Doesn’t Need to Be Ludacris’: Bayer signs rapper-actor to multivitamin campaign
- Rocket plots measured trajectory for new gene therapy Kresladi after clearance to launch from FDA
- Healthy Lab Results May Mask Future Risks for Kids with Obesity
- At-Home Chemotherapy Is Safe, Feasible, Pilot Study Indicates
- What You Do While Sitting Could Predict Dementia Risk
- New Cholesterol Guidelines: What Patients and Caregivers Need to Know
- Want A Bootlicking Yes Man? Ask An AI Chatbot For Advice, Study Warns
- Specially Coated Implants Better For Breast Cancer Patients, Study Finds
- Trump Team Claims Successes Against ACA Fraud While Pushing for More Controls
- Give and Take: Federal Rural Health Funding Could Trigger Service Cuts
- Fierce Pharma Asia—Takeda’s $1.3B reorg; India’s GLP-1 floodgates; Gilead’s $2.2B buy of a China NewCo
- Where are you with EUDAMED?
- Where are you with EUDAMED?
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Why private practice dentistry needs a better model
- CareQuest Innovation Partners, Kno2 collab on medical-dental data integration
- Nonprofit highlights rural opioid care strategies
- Vitana Pediatric & Orthodontic Partners adds Florida practice
- What the Health? From KFF Health News: A Headless CDC
- 20 behavioral health leaders challenge industry assumptions
- Recordati confirms it's weighing CVC Capital buyout offer of $12.6B
- 3 California behavioral health centers to close amid funding shifts
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- UnitedHealth shareholder sues over proposal to include details on integration in annual proxy
- SCAN taps biopharma, CMS vet Aman Bhandari as its first chief AI officer
- Infosys to acquire Optimum Healthcare IT in $465M deal
- DOJ alleges NewYork-Presbyterian forces payers into anticompetitive 'all-or-nothing' contracts
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Trump admin delays nomination for new CDC director past deadline
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- Remarks at the Financial Stability Oversight Council Meeting
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- New therapy animal program aims to support 100K patients, providers
- Pulse check on Lilly's GLP-1 fortunes
- Gen Z nurses prioritize schedule flexibility, need more manager interactions to avoid turnover
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
Abortions are illegal in Georgia after 6 weeks of pregnancy. Here we have the sad case of a woman who gave birth to a premature girl well after that period with "major health issues," after taking misoprostol and illegal oxycodone. This case could set legal precedents, depending upon the full facts of the matter and the progression of legal process:
Georgia woman faces murder charge after taking abortion pill
By Jasper Ward - March 21, 2026Summary
- Advocacy group calls charges 'cruel and unjust'
- Georgia has a ban on nearly all abortions
- Newborn was reportedly born at 22- to 24-weeks gestation
- Woman told friend she did not want another child, police say
March 20 (Reuters) - A 31-year-old Georgia woman has been charged with murder after she took abortion medication and gave birth to a premature infant who died within hours, according to court documents and arrest records.
Alexia Moore was arrested, charged and jailed by local police earlier this month in coastal Camden County, Georgia, near the Florida border over the episode on December 30.
Nearly all abortions in Georgia are illegal after six weeks of pregnancy. Since the U.S. Supreme Court's overturned Roe v. Wade in 2022, eliminating the constitutional right to abortion, many states have adopted abortion bans.
While other states have sought to prosecute women who had abortions, it is rare they are charged with murder as Moore was. It will be up to state prosecutors to decide whether to move forward with the case.
Moore, who already has two young children, took the abortion medication misoprostol at home then was rushed to the Southeast Georgia Health System Camden Campus on December 30, after experiencing severe pain, according to a police report.
She informed staff of her pregnancy and said she had taken 200 mg of misoprostol before arriving at the emergency room. A friend later told police that Moore took the abortion pill because she did not want another child.
While at the health center, the 31-year-old gave birth to a premature girl who police described as having "major health issues." Police said Moore also took illegal oxycodone, an opioid.
The newborn survived about an hour. The police report did not indicate weeks of gestation for the infant, but the Washington Post reported that Moore was between 22 and 24 weeks pregnant.
A lawyer for Moore could not immediately be reached for comment.
Dana Sussman, senior vice president at advocacy group Pregnancy Justice, said the Georgia case has no basis in the law and that it should be met with a vigorous defense on several grounds.
Georgia's abortion law "does not contemplate murder charges for someone who has an abortion, and self-managing an abortion is not a criminal act in Georgia. Charging Ms. Moore with murder is cruel and unjust," Sussman said in a statement.
Legal action by states that have banned or restricted abortion has largely been targeted at providers, including doctors who prescribe abortion medications remotely and dispense them through the mail.
Meanwhile, several Republican-led states including Texas and Florida are pursuing legal challenges to federal rules that have eased access to abortion drugs, including a 2023 regulation allowing them to be dispensed through the mail.
Judge Orders $ 1 Bond For Murder Charge Plus $ 2,000 Bond For 2 Drug Charges:
Judge grants $1 murder bond for Georgia woman accused of using pills to induce second-trimester abortion
Alexia Moore, 31, was approximately five months pregnant, according to a police warrant
By Landon Mion - March 24, 2026A Georgia judge granted a bond of only $1 to a woman charged with murder after she allegedly took pills to induce an abortion at approximately five months pregnant, which is illegal under the state's abortion restrictions.
Alexia Moore, 31, has spent nearly three weeks behind bars in coastal Camden County after her arrest on March 4, when police used an arrest warrant with language that mirrors the state's abortion ban after six weeks gestation.
"I think that charge is extremely problematic," Superior Court Judge Steven Blackerby said of the murder charge during a bond hearing on Monday, according to The New York Times.
"That is going to be a hard charge to convict upon," the judge continued.
Blackerby set Moore's total bond at $2,001, ordering $1,000 bond amounts for each of her two drug charges on top of the murder charge.
Moore's case is among the first in Georgia of a woman facing charges for terminating a pregnancy since the Peach State's abortion ban was adopted in 2019, banning abortions after embryonic cardiac activity can be detected, which is typically at about six weeks gestation.
District Attorney Keith Higgins of the Brunswick Judicial Circuit did not challenge the $1 bond in court on Monday and told the judge that police did not contact his office before charging Moore, according to reports.
Higgins' office would need to obtain a grand jury indictment before it could take Moore to trial.
Moore posted bond and was released on Monday, jail records show.
"Today’s decision is a reminder that justice is not served by accusation alone," attorneys from the Georgia Public Defender Council, who are representing Moore, said in a statement.
"Our system works best when courts carefully weigh the facts, uphold constitutional protections, and safeguard the rights of every person who comes before them," the statement added.
Moore arrived at a hospital on Dec. 30 and said she was suffering from abdominal pain, according to court records. She told hospital staff that she took misoprostol, a drug used to cause abortions, and the opioid painkiller oxycodone, according to an arrest warrant obtained by police in Kingsland, Georgia.
The baby survived for about an hour after being delivered at the hospital, according to the warrant.
The warrant states that police obtained medical records estimating that Moore had been pregnant for 22 to 24 weeks. The document also cited "the medical staff’s knowledge that the baby had a beating heart and was struggling to breathe."
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.

















